Alex Duncan

Alex Duncan

Company: Walden Biosciences

Job title: Chief Scientific Officer

Seminars:

Proteomic Insights Into Causality & WAL0921 Treatment Effects in suPARDriven CKD 2:30 pm

Further evidence for suPAR driven progression in rare kidney disease indications WAL0921 as a suPAR reducing agent in kidney therapy Proteomic data insights into mechanism of action of anti-suPAR treatmentRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.